Back to search

INT-BILAT-BILAT-ordningen

Travel Grant for American Association for Cancer Research (AACR) Conference

Awarded: NOK 61,188

Arctic Pharma's research team will travel to the United States to attend a scientific meeting in the field of cancer. The American Association for Cancer Research (AACR) conference brings leading scientists both from academia and industry. Participating in this event will provide a unique opportunity to have meetings with leaders in cancer. These meetings can greatly benefit Arctic Pharma as we can expand our network and discuss potential future cooperations. Arctic Pharma is currently focused on developing therapies for breast cancer. We are especially interested in the highly aggressive, high relapse rate and poor survival rate, triple-negative breast cancer subtype. Our preliminary studies suggest that our breast cancer therapies have the potential to also inhibit other aggressive cancer types, e.g. pancreatic cancer. Also we are in the process of initiating animal studies using our most promising inhibitors. We are at a crucial stage, where we need to develop a plan to take our inhibitors from preclinical stage to clinical trials. Thus attending this meeting will provide us with the opportunity to meet and establish cooperations and build relationships with experts in other aggressive cancer types, other technologies that would be applicable to our technology e.g. biomarkers, and those that have successfully taken a drug candidate from bench to bedside.

Funding scheme:

INT-BILAT-BILAT-ordningen